Study of CUDC 305 to assess the safety and efficacy in patient with systemic mastocytosis and glioblastoma multiforme.
Phase of Trial: Phase II
Latest Information Update: 12 May 2015
At a glance
- Drugs CUDC 305 (Primary)
- Indications Glioblastoma; Systemic mastocytosis
- Focus Therapeutic Use
- 12 May 2015 New trial record